Sysmex America Signs Exclusive Distribution Agreement with Swedish Company
MUNDELEIN, Ill. and LUND, Sweden. Sysmex America, Inc., a leading medical diagnostic instrument manufacturer and information systems developer, has signed an exclusive distribution agreement with Swedish company CellaVision AB, allowing Sysmex to distribute the CellaVision(TM) DM96 Digital Cell morphology System to hematology laboratories in the United States. The U.S. launch of the CellaVision DM96 is tentatively planned for March 2004 post-FDA clearance.
Under the terms of the agreement, Sysmex America will have the exclusive right to distribute the CellaVision(TM) DM96 and will be responsible for the system's sales, marketing and service support. CellaVision's U.S. subsidiary, headquartered in Jupiter, Florida, will continue to provide service support to CellaVision's existing U.S. customer base. The CellaVision DM96 Digital Cell Morphology System will be showcased in the Sysmex exhibit booth from March 28 - 30 at the CLMA/ASCP 2004 Annual Conference and Exhibition in Atlanta, Georgia.
"The value-added contribution that the CellaVision DM96 Digital Cell Morphology System will bring to our hematology solutions offering will greatly enhance the quality of results and the productivity of laboratories performing high-volume testing," said John Kershaw, COO, Sysmex America, Inc.
"This product distribution agreement with Sysmex America, which marks the continuation of our companies' collaboration that first began in 2001 with Sysmex Europe GmbH, represents an extraordinary opportunity for CellaVision to significantly expand its market presence in the United States. We look forward to extending our working relationship with this highly regarded diagnostics company," said Yvonne Martensson, CEO, CellaVision AB.
The CellaVision DM96 locates, identifies, and pre-classifies blood cells by means of automatic microscopy and advanced image processing thereby minimizing workload and producing faster results.
Most read news
Other news from the department business & finance
These products might interest you

Systec H-Series by Systec
Safe, reproducible and validatable sterilization of liquids, solids and waste
Autoclaves with 65-1580 liters usable space, flexibly expandable for various applications

Whatman™ folded filter papers by Cytiva
Whatman folded filter papers
Convenient folded formats speed up your sample preparation

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.